BioSpace News Archive

With 3 Approvals in 2019, Companies See Great Future for ADC Therapies

Part of that exponential approval growth is due to a greater understanding of the development process and are pairing the right antibodies with the appropriate toxic agents.

January 6, 2020
·
2 min read
·
Alex Keown
BioMidwest

New Insights Into Molecular Interactions Could Lead to Faster Drug Discovery

Biomedical engineers at the University of Minnesota conducted a first-of-its-kind study on molecular interactions.

January 6, 2020
·
2 min read
·
Mark Terry
Business

Merck Strikes Deal with Taiho and Astex to Develop Therapies Targeting KRAS Mutations

The three-way deal is focused on the development of small molecule inhibitors against several drug targets, including the KRAS oncogene, which are currently being investigated for the treatment of cancer.

January 6, 2020
·
2 min read
·
Alex Keown
VC Funding for Artificial Intelligence in Drug Development Climbs to $5.2 Billion

A recent market report by Signify Research found that venture capital investment for AI in drug development and clinical trials had reached $5.2 billion, although it pointed to investments slowing down in 2019 with only four new companies being formed.

January 6, 2020
·
3 min read
·
Mark Terry
3 Questions That Will Help You Set New Year Goals

Whether you’ve had your review or are gearing up for it, asking career-related questions can help increase productivity. These questions can help you set new year goals.

January 6, 2020
·
2 min read
·
Laura Brothers
Policy

AstraZeneca’s Farxiga on the Fast Track for Heart Failure Approval

Three months after it won approval in type 2 diabetes, AstraZeneca’s Farxiga is eying potential regulatory win as a treatment in heart failure patients.

January 6, 2020
·
2 min read
·
Alex Keown
BioForest

48 New Novel Drugs Approved by the FDA in 2019

This is a list of new molecular entities and new therapeutic biological products approved by the agency’s Center for Biologics Evaluation and Research in 2019.

January 6, 2020
·
4 min read
·
Mark Terry
Genetown

Where Are They Now? Top 3 Biotech Startups From NextGen Bio Class of 2018

Here’s a look at the top three companies from the “Top 20 Life Science Startups to Watch in 2018.”

January 6, 2020
·
4 min read
·
Mark Terry
ZEISS enhances efficiency in multi-scale and multi-modal workflows

Researchers benefit from faster FIB-SEM sample preparation, more accurate 3D tomography and greater integration in data reporting

January 6, 2020
·
5 min read
Drug Development

Pfizer and Merck KGaA’s Checkpoint Inhibitor Prolongs Survival in Urothelial Carcinoma

“Bavencio is the first immunotherapy to demonstrate in a clinical trial a statistically significant improvement in overall survival as a first-line treatment for patients with advanced urothelial carcinoma,” said Chris Boshoff, chief development officer, Oncology, Pfizer Global Product Development.

January 6, 2020
·
2 min read
·
Mark Terry